Workshop 16 |
Hypertension and the brain |
|
Saturday 5 April 2003 |
||
Organizer |
A. Semplicini (Padova, Italy) | |
Sponsors |
Neopharmed Takeda Merck, Sharp & Dohme Abbott Stroder Chiesi |
|
Cerebrovascular complications of hypertension: actual and future developments |
||
Session I |
|
|
Chairs |
A.C. Pessina (Padova, Italy) & A. Lechi (Verona, Italy) | Abstract No. |
| 14.00 - 14.10 | Welcome and introduction: hard versus soft cerebrovascular
end points in clinical trials A. Semplicini (Padova, Italy) |
|
| 14.10 - 14.30 | Hypertension and stroke: epidemiology and prevention C. Cuspidi (Milan, Italy) |
|
| 14.30 - 14.50 | Hypertension and stroke: epidemiology and prevention G. Leonetti (Milan, Italy) |
|
Session II |
Round table |
|
Chairs |
P. Amodio (Padova, Italy) & G. Meneghetti (Padova, Italy) | |
| 14.50 - 15.10 | Neuropsychological testing in the early detection of cognitive
dysfuntion in hypertension C.A. Umiltà (Padova, Italy) |
|
| 15.10 - 15.30 | US studies in the evaluation of the risk of developing vascular
dementia N. Bornstein (Tel-Aviv, Israel) |
|
| 15.30 - 15.50 | Biochemical markers of cerebral ischaemia P. Madeddu and C. Emanueli (Sassari, Italy) |
|
| 15.50 - 16.10 | PET / SPET in the assessment of cerebral perfusion and metabolism A. Cagnin (Padova, Italy) |
|
| 16.10 - 16.20 | coffee break | |
| 16.20 - 16.40 | The neurophysiological tools in the assessment of early mental
changes associated to severe hypertension G. Barrett (Fareham, UK) |
|
| 16.40 - 17.00 | Neuroimaging P. Scheltens (Amsterdam, The Netherlands) |
|
| 17.00 - 17.30 | Discussion | |
| 17.30 - 17.45 | Cognitive decline and diabetes type 1 F. Del Piccolo, D. Mapelli, A. Maran, C. Crepaldi, P. Amodio,and C. Umiltà (Padova, Italy) |
226 |
| 17.45 - 18.00 | Impaired cerebral vasoreactivity in hypertensives: an early
marker of vascular dementia? A. Realdi, V. Mascagna, L. Ciccariello, L. Macchini, F. Del Piccolo, P. Amodio, D. Mapelli, A.M. Maresca, and A. Semplicini (Padua, Italy) |
227 |
| 18.00 | End of workshop | |